Skip to content

Vinorelbine

Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.
Trade Name Navelbine
Common Name Vinorelbine
Indication breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, ovarian neoplasms
Drug Class Vinca alkaloids
Vinorelbine
Get full access now